NEW YORK, NY — (Marketwired) — 04/18/13 — John Holland, head of research at , will present “Crowd-sourcing and Telemonitoring: Better Data at Lower Cost” at the in Orlando, Fla., April 21-24.
Holland will discuss how telemonitoring technology can streamline data-collection and improve the cost-effectiveness and efficiency of drug development enabling pharmaceutical developers to detect signals of efficacy at lower cost, with less risk. This presentation will take place on Monday, April 22nd at 10:15 a.m. during the conference-s Cost & Contract Management Summit.
“Pharmaceutical companies are facing enormous clinical trial challenges that include enrolling and retaining participants, collecting accurate data, and analyzing and reporting the results in a timely manner,” stated Holland. “The Partnerships in Clinical Trials Conference offers a unique opportunity to increase awareness about innovations in telemonitoring technology that can help transform drug development by shifting data collection from a research site to the subject-s home, making it easier for patients to participate in clinical trials and enabling pharmaceutical companies to bring medications to market faster and more affordably.”
Holland will also participate in a panel discussion, “The Frontier of Innovation: Takeaways for Big Pharma,” on April 22 at 2:45 p.m. as part of a session on Partnering for Success in Virtual R&D. He will explore extending the virtual clinical trial concept from the contract research organization into the patient-s home.
The four-day conference, the pharmaceutical industry-s premiere clinical trial partnering event, will bring together senior-level clinical decision-makers focused on innovation in the clinical trial process. It will feature case studies and presentations by more than 80 respected pharmaceutical, biotech and medical device industry experts, including keynote speakers such as Eric Topol, MD, a world-renowned cardiologist who is director of The Scripps Translational Science Institute, professor of genomics at The Scripps Research Institute and a leader in the movement to use technology to modernize medical treatment; Jonathan Gruber, an economist at the Massachusetts Institute of Technology who was a key advisor to President Obama on the Affordable Care Act; and Deborah W. Brooks, co-founder and executive vice chairman of The Michael J. Fox Foundation for Parkinson-s Research.
Headquartered in New York City, AMC Health is a leading provider of telehealth solutions that provide customized, scalable, cost-effective programs that assist organizations serving at-risk populations and conducting clinical trials. A proven combination of technology and end-to-end support services enables safe, dependable monitoring at home. AMC Health-s remote patient monitoring programs deliver clinically actionable information that improves the quality and reduces the cost of clinical trials, enhances care coordination, improves patient outcomes and reduces the overall cost of healthcare. For more information, visit .
Contact:
Jan Shulman
Amendola Communications for AMC Health
480-664-8412 ext. 12
You must be logged in to post a comment Login